Clinical validation of the Cervista® high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study

Clinical validation of the Cervista® high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study

Xiaodan Mao,1 Guanyu Ruan,1 Binhua Dong,1 Lihua Chen,1 Shuxia Xu,2 Fen Lin,1 Pengming Sun1,31Laboratory of Gynecologic Oncology, Fujian Provincial Maternity and Children’s Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China; 2Department of Pathology, Fujian Pr...

Full description

Bibliographic Details
Main Authors: Mao X, Ruan G, Dong B, Chen L, Xu S, Lin F, Sun P
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Therapeutics and Clinical Risk Management
Subjects:
High-risk human papillomavirus
Cervista
Cytology
Pathologic diagnosis
Cervical cancer
Online Access:https://www.dovepress.com/clinical-validation-of-the-cervistareg-high-risk-human-papillomavirus--peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/clinical-validation-of-the-cervistareg-high-risk-human-papillomavirus--peer-reviewed-article-TCRM

Similar Items